Journal article
Abstract OT1-07-01: MRI screening versus symptom-directed surveillance for brain metastases among patients with triple negative or HER2+ metastatic breast cancer: A pilot study (nct03881605)
Abstract
Abstract
Background: The incidence of brain metastases (BrM) has steadily increased over time as women with metastatic breast cancer (MBC) live longer and survive to experience spread of cancer to the central nervous system (CNS). Women with triple negative and HER2+ MBC, which represent 30-40% of the MBC population, are at particularly high risk of BrM. At present, MBC patients are not screened for BrM; rather, they undergo …
Authors
Jerzak KJ; Sahgal A; Pond G; Brastianos PK; Freedman O; Stanisz G; Warner E
Journal
Cancer Research, Vol. 82, No. 4_Supplement,
Publisher
American Association for Cancer Research (AACR)
Publication Date
February 15, 2022
DOI
10.1158/1538-7445.sabcs21-ot1-07-01
ISSN
0008-5472